In: Nursing
1. List the select prototype medication for the
HMG-CoA reductase inhibitors (statins). There is only one prototype
drug for this class.
2. Describe myopathy. List the nursing actions and
client education regarding myopathy.
3. Heparin is the select prototype medication for
parenteral anticoagulants. List 2 complications of heparin and give
at least 2 nursing actions for each complication.
4. What are the therapeutic uses for the oral
anticoagulant warfarin?
5. What are the therapeutic uses for
Dabigatran?
1. HMG CoA is a enzyme that is responsible for the synthesis of the mevalonate. Mevalonate is a naturally occurring substance in body that is used by the body to make sterols such as chlosterols. HMG CoA reductase inhibitors block these enzymes.
HMG CoA reaductase inhibitors are :
Atorvastatin, Siimvastatin, rosuvastatin, Pitavastatin, Paravastatin, and Lovastatin.
Lovastatin is the one prototype medication out of this list.
2. Myopathy: Myo means muscles and pathy means surfing so myopathy is the disease of muscles in which due to muscle weakness muscles do not work properly.
Nurse will ask the patient to do some physical exercises daily from low level and raising the level accordingly which includes walking. But it should be raised till you get fatigue not more then that.
3. Heparin complications:
A. Low platelet level warning: due to heparin platelet level decreases so those patients who already have low level of platlets should not be given to them.
So nursing action: to check the platelet count of the patient in advance to prevent any kind of the complication.
B. Bleeding risk warning: due to heprarin blood cloting takes long time because it is a blood thinning agent. So complication is loss of large amount of blood due to any injury
So nursing action is to check if patient complains for having heavy periods or blood in gum or frequent nose bleeding etc.
4. Warfarin:
Therapeutic uses: treatment of venous thrombosis and pulmonary embolism.
5. Dabigartun:
Therapeutic uses: treatment of deep vein thrombosis and pulmonary embolism